A team of researchers led by Xiaoguang Dong, assistant professor of mechanical and biomedical engineering at Vanderbilt ...
The FDA approved vonoprazan (Voquezna) as a daily treatment for heartburn associated with non-erosive gastroesophageal reflux disease (GERD) in adults. GERD is a condition in which acidic stomach ...
Certain foods and drinks can trigger or worsen acid reflux symptoms. Identifying and avoiding these triggers is a crucial first step in managing the condition naturally. Common Acid Reflux Triggers: ...
Phathom Pharmaceuticals (NASDAQ:PHAT) is a good biotech to keep an eye on in the coming months because it is gearing up to potentially receive an expanded FDA approval of its drug Voquenza as a daily ...
Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal (GI) diseases, today announced its ...
November 25, 2024 (Houston Style Magazine) — Millions of Americans experience the discomfort of acid reflux, and let’s be honest—nothing ruins a big meal faster than that fiery sensation creeping up ...
Please provide your email address to receive an email when new articles are posted on . Proton pump inhibitors with histamine 2 receptor antagonists reduced all-cause mortality in patients with ...
Idiopathic pulmonary fibrosis (IPF) is a rapidly progressive, fatal disease of unknown cause. Although there is no known cure, there have been indications that gastroesophageal reflux disease (GERD) ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback